Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review Including Key Players Allergan Plc, Biogen
Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review, H1 2019 is latest pipeline review released by HTF MI to provides comprehensive information on the therapeutics under development for Trigeminal Neuralgia, complete with analysis by stage of development, drug target, root cause analysis ,mechanism of action (MoA), route of administration (RoA) and molecule type.
View full press release